Skip to main content
Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,223
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,844
Class I recallsReasonable probability of serious health consequences
24,370
Class II recallsTemporary or medically reversible health consequences
2,896
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,073 recalls
Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/frutas-y-hortalizas-del-sur-sa-expands-recalls-include-additional-lots-great-value-frozen-organicPublished October 2, 2026
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,725 recalls have been announced year to date.
  • Sep 2026 was 7% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (300).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,370
Class I9,844
Class III2,896
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,370
Class I9,844
Class III2,896
Not Yet Classified2

Showing 20,141–20,160 of 20,563 recalls

FDA Recall Terminated Historical recordClass III

Perindopril Erbumine Tablets, 8mg, 100 Tablets per Bottle, Rx Only, Boehringer Ingelheim, Roxane Laboratories Inc., Columbus, OH 43216, NDC 0054-0112-25.

by Boehringer Ingelheim Roxane Inc

Reason
Impurities/Degradation Products: Out of Specification results found for impurity B, identified as the drug's metabolite.
Published
January 23, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Prednisone tablets, USP, 10mg, Rx Only, Units of Use, NDC: a) 45802-303-67, 48-count Cartons, b) 45802-303-21, 21-count Cartons, Manufactured by: West-Ward Pharmaceutical Corporation, Eastown, NJ 07724, Distributed by: Perrigo, Allegan, MI 49040.

by L. Perrigo Co.

Reason
Presence of Foreign Substance(s); Perrigo has been notified of a recall by the manufacturer of this product, West-Ward Pharmaceuticals. This is a sub-recall due to tablets contaminated with trace amounts of food-grade lubricant, as well as stainless steel inclusions
Published
January 23, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Triamcinolone 10 mg/mL P, 40mg/mL P, 40mg/mL PF and 80 mg/mL PF in 1 mL, 2 mL, 5 mL, and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA

by New England Compounding Center

Reason
Lack of Assurance of Sterility
Published
January 9, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Saline 10% and 3%, in 5 mL and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA

by New England Compounding Center

Reason
Lack of Assurance of Sterility
Published
January 9, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Omnipaque 240mg/mL PF, 300mg/mL PF, in 3 mL, 5 mL, and 10 mL, vials, manufactured by New England Compounding Center, Framingham, MA

by New England Compounding Center

Reason
Lack of Assurance of Sterility
Published
January 9, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Lidocaine 1% PF, 2% PF, and 4% PF, in 1 mL, 2 mL, 5 mL, and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA

by New England Compounding Center

Reason
Lack of Assurance of Sterility
Published
January 9, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Lidocaine/Dextrose 5%/7.5% PF, manufactured by New England Compounding Center, Framingham, MA

by New England Compounding Center

Reason
Lack of Assurance of Sterility
Published
January 9, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Isovue 200 mg/mL PF and 300 mg/mL PF, Vials, manufactured by New England Compounding Center, Framingham, MA

by New England Compounding Center

Reason
Lack of Assurance of Sterility
Published
January 9, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Hyaluronidase 150 u/ml PF, 1 mL, 5 mL, and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA

by New England Compounding Center

Reason
Lack of Assurance of Sterility
Published
January 9, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Glycerin 100% PF, 1mL, 2 mL, and 5 mL vials, manufactured by New England Compounding Center, Framingham, MA

by New England Compounding Center

Reason
Lack of Assurance of Sterility
Published
January 9, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dexamethasone Sodium Phosphate 4 mg/mL vials PF, 6 mg/mL PF vials, and 8 mg/mL PF vials, manufactured by New England Compounding Center, Framingham, MA

by New England Compounding Center

Reason
Lack of Assurance of Sterility
Published
January 9, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Clonidine 100 mcg/mL PF, 1mL and 2 mL vials, manufactured by New England Compounding Center, Framingham, MA

by New England Compounding Center

Reason
Lack of Assurance of Sterility
Published
January 9, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Bupivacaine 0.25% PF, Bupivacaine 0.5% PF, and Bupivacaine 0.75% PF, manufactured by New England Compounding Center, Framingham, MA

by New England Compounding Center

Reason
Lack of Assurance of Sterility
Published
January 9, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Betamethasone Sodium Phosphate 6 mg/mL P Injection, Betamethasone Sodium Phosphate 6 mg/mL PF Injection, Betamethasone Sodium Phosphate 8 mg/mL PF Injection, Betamethasone Sodium Phosphate 12 mg/mL PF Injection, manufactured by New England Compounding Center, Framingham, MA

by New England Compounding Center

Reason
Lack of Assurance of Sterility
Published
January 9, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Betamethasone Repository 6 mg/mL PF Injection and Betamethasone Repository 6 mg/mL P Injection, manufactured by New England Compounding Center, Framingham, MA

by New England Compounding Center

Reason
Lack of Assurance of Sterility
Published
January 9, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Methylprednisolone Acetate 80 mg/mL Injection, Preserved, supplied in 5 mL and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA

by New England Compounding Center

Reason
Non-Sterility
Published
January 9, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Methylprednisolone Acetate 40 mg/mL Injection, Preserved, supplied in 5 mL and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA

by New England Compounding Center

Reason
Non-Sterility
Published
January 9, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Methylprednisolone Acetate (PF) 40 mg/ml Injection, supplied in 1 mL, 2 mL and 5 mL vials, manufactured by New England Compounding Center, Framingham, MA

by New England Compounding Center

Reason
Non-Sterility
Published
January 9, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Methylprednisolone Acetate (PF) 80 mg/ml Injection, supplied in 1 mL, 2 mL and 5 mL vials, manufactured by New England Compounding Center, Framingham, MA

by New England Compounding Center

Reason
Non-Sterility
Published
January 9, 2013
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Synthroid (Levothyroxine Sodium) tablets, 150 mcg (0.15 mg), 90 tablets per bottle, Rx Only, NDC 0074-7069-90; ABBOTT LABORATORIES NORTH CHICAGO, IL 60064 U.S.A.

by Abbott Laboratories

Reason
Labeling: Error on Declared Strength. Product labeled to contain 150 mcg tablets actually contained 75 mcg tablets.
Published
January 9, 2013
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.